Statistics

Total Visits

Views
Validation of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model (IMRCC), in patients (pt) treated with pazopanib (Pz) as first line for metastatic renal carcinoma (mRC): First results of the SOGUG SPAZO study46

Select a period of time:

Number of views in the range

Views
Validation of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model (IMRCC), in patients (pt) treated with pazopanib (Pz) as first line for metastatic renal carcinoma (mRC): First results of the SOGUG SPAZO study3

Views

Views
October 20250
November 20250
December 20250
January 20260
February 20260
March 20263
April 20260
Download CSV file
 untranslated
 untranslated

Top country views

Views
Mexico2
Finland1
 

Top cities views

Views
Acapulco de Juárez1
Helsinki1
Tijuana1